Irvine, CA – ChromaDex, Inc., (www.chromadex.com) the world leader in phytochemical reference standards and contract testing, announces the release of the Hoodia oxypregnane steroidal glycoside reference standard P57.
In addition to the complete characterization regarding the identity, purity, and moisture content of the P57 standard conducted by Chromadex, the ChromaDex P57 standard will be independently reviewed. Upon data verification, the reference standard will be designated as an American Herbal Pharmacopoeia (AHP)-verified reference standard. AHP-Verified reference standards offer an independent verification of the already highly documented standards offered by ChromaDex. ChromaDex will also be offering a new Hoodia P57 HPLC testing kit, which includes the reference standard, the HPLC column, and the HPLC testing method. Contract testing is also available for Hoodia raw material identity by both HP-TLC and HPLC procedures.
Raw material identity through the use of scientifically valid testing methods is at the forefront of the cGMPs released by the FDA in June of 2007. ChromaDex can provide companies with the tools to ensure their raw material is indeed Hoodia.
“The market for Hoodia as a weight loss supplement continues to grow,” said ChromaDex Director of Technical Services and Marketing, Brian Schaneberg, PhD, “a well characterized standard is now commercially available to accurately quantify P57 in Hoodia raw material and related finished products”.
ChromaDex, Inc., a privately-held, Irvine, California based company, is a world leader in the development of Phytochemical and Botanical Reference Standards (www.chromadex.com). ChromaDex provides the dietary supplement, food, beverage, nutraceutical and cosmetic industries with the analytical tools, products, and services to meet the regulatory, quality, efficacy and safety standards for their products as defined by the current GMPs.
Contact: Tony Nguyen
Email: [email protected]